Skip to main content

Interferon alfa-2b Injection Shortage

Last Updated: January 10, 2022
Status: Current

Products Affected - Description
    • Intron A injection, Merck, 10 million units, vial, 1 count, NDC 00085-4350-01
    • Intron A injection, Merck, 18 million units, vial, 1 count, NDC 00085-4351-01
    • Intron A injection, Merck, 50 million units, vial, 1 count, NDC 00085-4352-01
    • Intron A injection, Merck, 10 million units/mL, 2.5 mL vial, 1 count, NDC 00085-1133-01
    • Intron A injection, Merck, 6 million units/mL, 3 mL vial, 1 count, NDC 00085-1168-01
Reason for the Shortage
    • Merck has made a business decision to discontinue all presentations of Intron A.
    • They are the sole suppliers of interferon alfa-2b.
Available Products
    • There is insufficient supply for usual ordering

Estimated Resupply Dates

    • Merck has discontinued all presentations of Intron A solution for injection.
    • Merck has discontinued all presentations of Intron A powder for injection.

Updated

Updated January 10, 2022 by Michelle Wheeler, PharmD, Drug Information Specialist. Created March 30, 2021 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer